Literature DB >> 22908154

Toxicity mechanisms of amphotericin B and its neutralization by conjugation with arabinogalactan.

Sarah Kagan1, Diana Ickowicz, Miriam Shmuel, Yoram Altschuler, Edward Sionov, Miriam Pitusi, Aryeh Weiss, Shimon Farber, Abraham J Domb, Itzhack Polacheck.   

Abstract

Amphotericin B (AMB) is an effective antifungal agent. However, its therapeutic use is hampered by its toxicity, mainly due to channel formation across kidney cell membranes and the disruption of postendocytic trafficking. We previously described a safe injectable AMB-arabinogalactan (AG) conjugate with neutralized toxicity. Here we studied the mechanism of the toxicity of free AMB and its neutralization by conjugation with AG. AMB treatment of a kidney cell line modulated the trafficking of three receptors (C-X-C chemokine receptor type 4 [CXCR4], M1 receptor, and human transferrin receptor [hTfnR]) due to an increase in endosomal pH. Similar data were also obtained in yeast but with an increase in vacuolar pH and the perturbation of Hxt2-green fluorescent protein (GFP) trafficking. The conjugation of AMB with AG neutralized all elements of the toxic activity of AMB in mammalian but not in fungal cells. Based on these results, we provide an explanation of how the conjugation of AMB with AG neutralizes its toxicity in mammalian cells and add to the knowledge of the mechanism of action of free AMB in both fungal and mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22908154      PMCID: PMC3486601          DOI: 10.1128/AAC.00612-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  54 in total

1.  Immunopurification and characterization of rat adipocyte caveolae suggest their dissociation from insulin signaling.

Authors:  Ricardo P Souto; Gino Vallega; Jonathan Wharton; Jorgen Vinten; Jorgen Tranum-Jensen; Paul F Pilch
Journal:  J Biol Chem       Date:  2003-03-11       Impact factor: 5.157

Review 2.  Antifungal agents: mechanisms of action.

Authors:  Frank C Odds; Alistair J P Brown; Neil A R Gow
Journal:  Trends Microbiol       Date:  2003-06       Impact factor: 17.079

Review 3.  Overview of the lipid formulations of amphotericin B.

Authors:  Bertrand Dupont
Journal:  J Antimicrob Chemother       Date:  2002-02       Impact factor: 5.790

Review 4.  Amphotericin B nephrotoxicity.

Authors:  Gilbert Deray
Journal:  J Antimicrob Chemother       Date:  2002-02       Impact factor: 5.790

5.  Comparative molecular dynamics simulations of amphotericin B-cholesterol/ergosterol membrane channels.

Authors:  Maciej Baginski; Haluk Resat; Edward Borowski
Journal:  Biochim Biophys Acta       Date:  2002-12-23

6.  Amphotericin B covalent dimers forming sterol-dependent ion-permeable membrane channels.

Authors:  Nobuaki Matsumori; Nahoko Yamaji; Shigeru Matsuoka; Tohru Oishi; Michio Murata
Journal:  J Am Chem Soc       Date:  2002-04-24       Impact factor: 15.419

7.  Ion passage pathways and thermodynamics of the amphotericin B membrane channel.

Authors:  Haluk Resat; Maciej Baginski
Journal:  Eur Biophys J       Date:  2002-04-13       Impact factor: 1.733

8.  Ion channel behavior of amphotericin B in sterol-free and cholesterol- or ergosterol-containing supported phosphatidylcholine bilayer model membranes investigated by electrochemistry and spectroscopy.

Authors:  Weimin Huang; Zheling Zhang; Xiaojun Han; Jilin Tang; Jianguo Wang; Shaojun Dong; Erkang Wang
Journal:  Biophys J       Date:  2002-12       Impact factor: 4.033

9.  Leukocyte-endothelium interaction promotes SDF-1-dependent polarization of CXCR4.

Authors:  Jaap D van Buul; Carlijn Voermans; Jose van Gelderen; Eloise C Anthony; C Ellen van der Schoot; Peter L Hordijk
Journal:  J Biol Chem       Date:  2003-05-23       Impact factor: 5.157

10.  Distinct mechanisms of agonist-induced endocytosis for human chemokine receptors CCR5 and CXCR4.

Authors:  Sundararajan Venkatesan; Jeremy J Rose; Robert Lodge; Philip M Murphy; John F Foley
Journal:  Mol Biol Cell       Date:  2003-05-03       Impact factor: 4.138

View more
  15 in total

1.  Cell Wall Changes in Amphotericin B-Resistant Strains from Candida tropicalis and Relationship with the Immune Responses Elicited by the Host.

Authors:  Ana C Mesa-Arango; Cristina Rueda; Elvira Román; Jessica Quintin; María C Terrón; Daniel Luque; Mihai G Netea; Jesus Pla; Oscar Zaragoza
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

2.  Nylon-3 polymers with selective antifungal activity.

Authors:  Runhui Liu; Xinyu Chen; Zvi Hayouka; Saswata Chakraborty; Shaun P Falk; Bernard Weisblum; Kristyn S Masters; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2013-04-02       Impact factor: 15.419

3.  Discovery of Short Peptides Exhibiting High Potency against Cryptococcus neoformans.

Authors:  Amit Mahindra; Nitin Bagra; Nishima Wangoo; Shabana I Khan; Melissa R Jacob; Rahul Jain
Journal:  ACS Med Chem Lett       Date:  2014-01-15       Impact factor: 4.345

4.  Synthetically modified L-histidine-rich peptidomimetics exhibit potent activity against Cryptococcus neoformans.

Authors:  Amit Mahindra; Nitin Bagra; Nishima Wangoo; Rohan Jain; Shabana I Khan; Melissa R Jacob; Rahul Jain
Journal:  Bioorg Med Chem Lett       Date:  2014-05-10       Impact factor: 2.823

5.  Activity of Auranofin against Multiple Genotypes of Naegleria fowleri and Its Synergistic Effect with Amphotericin B In Vitro.

Authors:  Jose Ignacio Escrig; Hye Jee Hahn; Anjan Debnath
Journal:  ACS Chem Neurosci       Date:  2020-05-26       Impact factor: 4.418

6.  Synthesis and Antimicrobial Activities of His(2-aryl)-Arg and Trp-His(2-aryl) Classes of Dipeptidomimetics.

Authors:  Amit Mahindra; Krishna K Sharma; Dinesh Rathore; Shabana I Khan; Melissa R Jacob; Rahul Jain
Journal:  Medchemcomm       Date:  2014-05-01       Impact factor: 3.597

7.  Enhanced Antifungal Activity by Ab-Modified Amphotericin B-Loaded Nanoparticles Using a pH-Responsive Block Copolymer.

Authors:  Xiaolong Tang; Jingjing Dai; Jun Xie; Yongqiang Zhu; Ming Zhu; Zhi Wang; Chunmei Xie; Aixia Yao; Tingting Liu; Xiaoyu Wang; Li Chen; Qinglin Jiang; Shulei Wang; Yong Liang; Congjing Xu
Journal:  Nanoscale Res Lett       Date:  2015-06-10       Impact factor: 4.703

Review 8.  Macrolides: From Toxins to Therapeutics.

Authors:  Kiersten D Lenz; Katja E Klosterman; Harshini Mukundan; Jessica Z Kubicek-Sutherland
Journal:  Toxins (Basel)       Date:  2021-05-12       Impact factor: 4.546

9.  Inhibition of nucleotide biosynthesis potentiates the antifungal activity of amphotericin B.

Authors:  Dithi Banerjee; Lauren Burkard; John C Panepinto
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

10.  Epidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program, 2008-2014.

Authors:  Snigdha Vallabhaneni; Angela A Cleveland; Monica M Farley; Lee H Harrison; William Schaffner; Zintar G Beldavs; Gordana Derado; Cau D Pham; Shawn R Lockhart; Rachel M Smith
Journal:  Open Forum Infect Dis       Date:  2015-12-14       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.